vs

Side-by-side financial comparison of Liberty Broadband Corp (LBRDA) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

Liberty Broadband Corp is the larger business by last-quarter revenue ($261.0M vs $186.7M, roughly 1.4× NEOGENOMICS INC). Liberty Broadband Corp runs the higher net margin — 146.7% vs -57.9%, a 204.6% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs 6.1%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs 4.3%).

Liberty Global Ltd. is a British-Dutch-American multinational telecommunications company domiciled in Bermuda, with headquarters in London, Amsterdam and Denver. Its respective legal names are Liberty Global Holdings Limited (UK), Liberty Global B.V. (Netherlands) and Liberty Global, Inc., with the first of these being publicly traded. It was formed in 2005 by the merger of the international arm of Liberty Media and UnitedGlobalCom (UGC).

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

LBRDA vs NEO — Head-to-Head

Bigger by revenue
LBRDA
LBRDA
1.4× larger
LBRDA
$261.0M
$186.7M
NEO
Growing faster (revenue YoY)
NEO
NEO
+5.0% gap
NEO
11.1%
6.1%
LBRDA
Higher net margin
LBRDA
LBRDA
204.6% more per $
LBRDA
146.7%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
4.3%
LBRDA

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
LBRDA
LBRDA
NEO
NEO
Revenue
$261.0M
$186.7M
Net Profit
$383.0M
$-108.0M
Gross Margin
43.3%
Operating Margin
15.7%
46.9%
Net Margin
146.7%
-57.9%
Revenue YoY
6.1%
11.1%
Net Profit YoY
96.4%
42.0%
EPS (diluted)
$2.68
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LBRDA
LBRDA
NEO
NEO
Q1 26
$186.7M
Q4 25
$190.2M
Q3 25
$187.8M
Q2 25
$261.0M
$181.3M
Q1 25
$266.0M
$168.0M
Q4 24
$263.0M
$172.0M
Q3 24
$262.0M
$167.8M
Q2 24
$246.0M
$164.5M
Net Profit
LBRDA
LBRDA
NEO
NEO
Q1 26
$-108.0M
Q4 25
Q3 25
$-27.1M
Q2 25
$383.0M
$-45.1M
Q1 25
$268.0M
$-25.9M
Q4 24
$291.0M
Q3 24
$142.0M
$-17.7M
Q2 24
$195.0M
$-18.6M
Gross Margin
LBRDA
LBRDA
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
LBRDA
LBRDA
NEO
NEO
Q1 26
46.9%
Q4 25
-7.1%
Q3 25
-14.4%
Q2 25
15.7%
-26.3%
Q1 25
16.2%
-16.6%
Q4 24
4.9%
-10.7%
Q3 24
11.5%
-12.6%
Q2 24
8.5%
-13.3%
Net Margin
LBRDA
LBRDA
NEO
NEO
Q1 26
-57.9%
Q4 25
Q3 25
-14.4%
Q2 25
146.7%
-24.9%
Q1 25
100.8%
-15.4%
Q4 24
110.6%
Q3 24
54.2%
-10.5%
Q2 24
79.3%
-11.3%
EPS (diluted)
LBRDA
LBRDA
NEO
NEO
Q1 26
$-0.13
Q4 25
Q3 25
Q2 25
$2.68
Q1 25
$1.87
Q4 24
$2.04
Q3 24
$0.99
Q2 24
$1.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LBRDA
LBRDA
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$180.0M
$146.1M
Total DebtLower is stronger
$3.1B
Stockholders' EquityBook value
$10.4B
$828.8M
Total Assets
$16.6B
$1.3B
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LBRDA
LBRDA
NEO
NEO
Q1 26
$146.1M
Q4 25
$159.6M
Q3 25
$164.1M
Q2 25
$180.0M
$154.7M
Q1 25
$226.0M
$346.2M
Q4 24
$163.0M
$367.0M
Q3 24
$168.0M
$362.0M
Q2 24
$73.0M
$355.1M
Total Debt
LBRDA
LBRDA
NEO
NEO
Q1 26
Q4 25
$341.9M
Q3 25
Q2 25
$3.1B
Q1 25
$3.8B
Q4 24
$3.8B
$541.1M
Q3 24
$3.7B
Q2 24
$3.6B
Stockholders' Equity
LBRDA
LBRDA
NEO
NEO
Q1 26
$828.8M
Q4 25
$836.6M
Q3 25
$838.3M
Q2 25
$10.4B
$854.0M
Q1 25
$10.1B
$888.3M
Q4 24
$9.8B
$902.3M
Q3 24
$9.5B
$908.2M
Q2 24
$9.3B
$915.9M
Total Assets
LBRDA
LBRDA
NEO
NEO
Q1 26
$1.3B
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$16.6B
$1.4B
Q1 25
$17.0B
$1.6B
Q4 24
$16.7B
$1.6B
Q3 24
$16.3B
$1.6B
Q2 24
$16.0B
$1.6B
Debt / Equity
LBRDA
LBRDA
NEO
NEO
Q1 26
Q4 25
0.41×
Q3 25
Q2 25
0.30×
Q1 25
0.38×
Q4 24
0.38×
0.60×
Q3 24
0.39×
Q2 24
0.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LBRDA
LBRDA
NEO
NEO
Operating Cash FlowLast quarter
$91.0M
$-8.1M
Free Cash FlowOCF − Capex
$37.0M
FCF MarginFCF / Revenue
14.2%
Capex IntensityCapex / Revenue
20.7%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$-49.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LBRDA
LBRDA
NEO
NEO
Q1 26
$-8.1M
Q4 25
$1.3M
Q3 25
$8.9M
Q2 25
$91.0M
$20.3M
Q1 25
$78.0M
$-25.3M
Q4 24
$1.0M
$9.8M
Q3 24
$24.0M
$9.2M
Q2 24
$27.0M
$13.9M
Free Cash Flow
LBRDA
LBRDA
NEO
NEO
Q1 26
Q4 25
$-6.5M
Q3 25
$570.0K
Q2 25
$37.0M
$14.0M
Q1 25
$13.0M
$-29.8M
Q4 24
$-63.0M
$-1.8M
Q3 24
$-36.0M
$-1.6M
Q2 24
$-35.0M
$814.0K
FCF Margin
LBRDA
LBRDA
NEO
NEO
Q1 26
Q4 25
-3.4%
Q3 25
0.3%
Q2 25
14.2%
7.7%
Q1 25
4.9%
-17.8%
Q4 24
-24.0%
-1.0%
Q3 24
-13.7%
-0.9%
Q2 24
-14.2%
0.5%
Capex Intensity
LBRDA
LBRDA
NEO
NEO
Q1 26
Q4 25
4.1%
Q3 25
4.4%
Q2 25
20.7%
3.5%
Q1 25
24.4%
2.7%
Q4 24
24.3%
6.7%
Q3 24
22.9%
6.4%
Q2 24
25.2%
8.0%
Cash Conversion
LBRDA
LBRDA
NEO
NEO
Q1 26
Q4 25
Q3 25
Q2 25
0.24×
Q1 25
0.29×
Q4 24
0.00×
Q3 24
0.17×
Q2 24
0.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons